3e étage
Québec, Québec
Canada G1E 7G9
- Côté, CamilleÉtudiant 2e cycle+1 418-525-4444, poste 20685camille.cote@crchudequebec.ulaval.ca
Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada
Article de revueLancet Healthy Longev, 4 (8), 2023.
Impact of chronic comorbidities on hospitalization, intensive care unit admission and death among adult vaccinated and unvaccinated COVID-19 confirmed cases during the Omicron wave
Article de revueJ Multimorb Comorb, 13 , 2023.
Increase of invasive pneumococcal disease in children temporally associated with RSV outbreak in Quebec: a time-series analysis
Article de revueLancet Reg Health Am, 19 , 2023.
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study
Article de revueLancet Infect Dis, 23 (1), 2023.
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada
Article de revueJAMA Netw Open, 5 (10), 2022.
Impact of the first vaccine dose on COVID-19 and its complications in long-term care facilities and private residences for seniors in Québec, Canada
Article de revueCan Commun Dis Rep, 48 (4), 2022.
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
Article de revueClin Infect Dis, 75 (11), 2022.
Exploring the associations between polypharmacy and COVID-19-related hospitalisations and deaths: a population-based cohort study among older adults in Quebec, Canada
Article de revueBMJ Open, 12 (3), 2022.
Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada
Article de revueClin Infect Dis, 75 (1), 2022.
Surveillance des hospitalisations associées à la COVID-19 et autres virus respiratoires, saison grippale 2020-2021
LivreInstitut national de santé publique du Québec, Québec, QC, 2021.
Projets terminés récemment
- CT21 QC29: Burden Ethnographic Modeling Evaluation Qaujilisaaqtuq (BEMEQ) RSV, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, du 2019-06-01 au 2022-03-31
- How to better manage infectious diseases in ER by triage with molecular mini-panels for the rapid detection of highly transmissible pathogens, Subvention, Consortium québécois sur la découverte du médicament, du 2018-10-01 au 2022-09-30